Méplan reviewed several SNP studies of selenoproteins and their relationship with prostate cancer and found that serum selenium and selenoprotein concentrations were related to prostate cancer only when the allele of TXNRD2 rs9605031 was CT/TT [102]. The gene discussed is TXNRD2; the disease is prostate cancer.